Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
2 drugs in development
By Therapeutic Area
top 2
R&D Momentum
51/100
Pipeline Velocity
22/100
Trial Completion Rate
67/100
Pipeline Concentration
38/100
Pipeline Freshness
82/100
Strategic Signals
Activity
Last 14 days
ACL Reconstruction Rehabilitation With Exercise and Psychological Support
Safety and Feasibility of Intranasal Insulin in Patients With Spinal Cord Injury
Earlier
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)